What we do Relic Technologies Ltd, founded in 1991, is primarily engaged in share broking and financial services, planning to diversify into pharmaceuticals and wellness products. |
Founded in 1,991 |
Market share Member of National Stock Exchange with institutional clients, positioning as a niche player in financial brokerage. |
Problem solved Provides brokerage services facilitating capital market investments and aims to expand into health and wellness sectors addressing pharmaceutical needs. |
Top clients or who we serve Institutional investors primarily, with future plans to serve broader health and wellness markets. |
Key management - |
Our journey and innovations Established as a brokerage firm in 1991; contemplating business diversification into pharma and wellness to fuel growth. |
Where we operate Operations mainly in India with membership on NSE and BSE; subsidiaries support pharma and wellness segments. |
Top products or what we offer Share broking services; upcoming health and wellness products through subsidiaries Relic Pharma Ltd and Truhealthy Wellness Pvt Ltd. |
Top brands - |
Raw materials needed - |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue largely cyclical, tied to capital market activities; new segments may add recurring streams. |
Our industry position Small but established player in Indian share broking; transitioning towards pharmaceutical and wellness sectors. |
Financial highlights FY 2024-25 revenue stood at INR 2.04 crores with net loss of INR 1.42 crores, reflecting investment in diversification. |
Geographical revenue split - |
Order book - |
Whats driving growth Growth driven by brokerage operations and strategic move towards health and wellness industries. |
Our future plans Diversify into pharmaceutical and wellness businesses, increase authorized capital, and strengthen subsidiaries. |
Our green promise - |
Our people and values Committed workforce focused on finance and upcoming pharma activities; values compliance and corporate governance. |
Key challenges ahead Financial losses, transition risks into new sectors, regulatory approvals, and market competition. |
Interesting facts Plans name change to Relic Life Science Ltd signalling focus shift; strengthened board with experienced directors. |
Risks and strategy Risks from diversification and financial losses mitigated by strong governance, risk management, and market repositioning. |
